Literature DB >> 3024845

Clinical aspects of prostaglandins and leukotrienes in migraine.

J Parantainen, H Vapaatalo, E Hokkanen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3024845

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  3 in total

1.  Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes.

Authors:  E Moilanen; J Alanko; A Juhakoski; H Vapaatalo
Journal:  Agents Actions       Date:  1989-08

Review 2.  New and emerging prophylactic agents for migraine.

Authors:  Abouch V Krymchantowski; Marcelo E Bigal; Pedro F Moreira
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.

Authors:  Abouch Valenty Krymchantowski; Marcelo Eduardo Bigal
Journal:  BMC Neurol       Date:  2004-06-28       Impact factor: 2.474
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.